financetom
Business
financetom
/
Business
/
Chemed Insider Sold Shares Worth $2,781,897, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Chemed Insider Sold Shares Worth $2,781,897, According to a Recent SEC Filing
Aug 9, 2024 11:35 AM

02:03 PM EDT, 08/09/2024 (MT Newswires) -- Thomas C Hutton, Director, Vice President, on August 06, 2024, sold 4,827 shares in Chemed ( CHE ) for $2,781,897. Following the Form 4 filing with the SEC, Hutton has control over a total of 32,765 shares of the company, with 32,765 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/19584/000095017024094535/xslF345X03/ownership.xml

Price: 580.47, Change: -2.91, Percent Change: -0.50

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Cardinal Health lifts annual profit outlook on strength in specialty medicines unit
Cardinal Health lifts annual profit outlook on strength in specialty medicines unit
Nov 3, 2024
Nov 1 (Reuters) - Cardinal Health ( CAH ) raised its 2025 adjusted profit forecast on Friday as strong demand for costly specialty medicines and branded drugs drove sales at its pharmaceuticals unit, sending the shares of the company up nearly 4% in premarket trading. Drug distributors have been trying to diversify their operations and gain better footing in the...
Biogen, Eisai Submit Biologics License Application for Alzheimer's Subcutaneous Autoinjector to US FDA
Biogen, Eisai Submit Biologics License Application for Alzheimer's Subcutaneous Autoinjector to US FDA
Nov 3, 2024
08:13 AM EDT, 11/01/2024 (MT Newswires) -- Biogen (BIIB) and Eisai said late Thursday that Eisai finalized a biologics license application rolling submission to the FDA for a subcutaneous autoinjector of LEQEMBI, or lecanemab-irmb, for weekly dosing in early-stage Alzheimer's disease. The device, which is designed for home or clinic use, allows a 15-second injection and supports sustained drug levels...
--Dominion Energy Keeps Quarterly Dividend at $0.6675 per Share, Payable Dec. 20 to Holders of Record Nov. 29
--Dominion Energy Keeps Quarterly Dividend at $0.6675 per Share, Payable Dec. 20 to Holders of Record Nov. 29
Nov 3, 2024
03:17 PM EDT, 10/31/2024 (MT Newswires) -- Price: 59.73, Change: +1.28, Percent Change: +2.18 ...
Cboe beats third-quarter profit estimates on strong hedging activity
Cboe beats third-quarter profit estimates on strong hedging activity
Nov 3, 2024
Nov 1 (Reuters) - Cboe Global Markets ( CBOE ) beat estimates for third-quarter profit on Friday, helped by strong options trading as investors actively hedged against geopolitical and economic uncertainties. A robust equities market, shifts in the U.S. Federal Reserve's key policy rates and the potential economic fallout from the Middle East conflict have investors and portfolio managers on...
Copyright 2023-2026 - www.financetom.com All Rights Reserved